IVVD Invivyd, Inc. - Common Stock
$0,80
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$0–$3
12% of range
Analystenbewertung
BUY
9 analysts
Kursziel
$10
+1145% upside
P/E (TTM)
-2.7
ROE
-36.9%
Nettogewinnmarge
-98.2%
IVVD Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.80
Marktkapitalisierung
$227M
P/E (TTM)
-2.7
EPS (TTM)
$-0.30
Umsatz (TTM)
$53M
Dividendenrendite
—
ROE
-36.9%
Verschuldungsgrad
—
52W-Spanne
$0 – $3
IVVD Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$53M
2023-12-31
→
2025-12-31
EPS
$-0.30
2021-12-31
→
2025-12-31
Freier Cashflow
$-58M
2022-12-31
→
2025-12-31
Margen
-98.2%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
IVVD
Peer-Median
P/E (TTM)
-2.7
—
P/S (TTM) (K/V (TTM))
4.2
9.2
P/B (K/B)
0.9
1.4
Price / FCF (Kurs / FCF)
-3.9
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
IVVD
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-104.0%
—
Net Profit Margin (Nettogewinnmarge)
-98.2%
-312.6%
ROA
-25.8%
-58.9%
ROE
-36.9%
-83.3%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
IVVD
Peer-Median
Current Ratio (Liquiditätsgrad)
7.2
8.5
Quick Ratio
7.0
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
IVVD
Peer-Median
Revenue YoY (Umsatz YoY)
110.5%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
IVVD
Peer-Median
IVVD Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
9 Analysten
- Starker Kauf 3 33,3%
- Kauf 5 55,6%
- Halten 1 11,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
3 Analysten · 2026-08-16
Tief
$10.00
Hoch
$10.00
Median-Ziel
$10.00
+1144,6%
Mittelwert-Ziel
$10.00
+1144,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.04%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.13 | $-0.07 | -0.06% |
| 31. Dezember 2025 | $-0.04 | $-0.09 | 0.05% |
| 30. September 2025 | $-0.06 | $-0.08 | 0.02% |
| 30. Juni 2025 | $-0.12 | $-0.02 | -0.10% |
| 31. März 2025 | $-0.14 | $-0.03 | -0.11% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| IMUX | — | -0.9 | — | — | — | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| PEPG | $448M | -3.1 | — | — | -82.0% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $53M | $25M | $0 | |
| R&D Expense | $38M | $137M | $159M | |
| SG&A Expense | $67M | $63M | $49M | |
| Operating Expenses | $109M | $202M | $213M | |
| Operating Income | $-56M | $-177M | $-213M | |
| Other Non-op | $3M | $7M | $14M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-52M | $-170M | $-199M | |
| EPS (Basic) | $-0.30 | $-1.43 | $-1.81 | |
| EPS (Diluted) | $-0.30 | $-1.43 | $-1.81 | |
| Shares (Basic) | 172,212,902 | 118,555,073 | 109,526,053 | |
| Shares (Diluted) | 172,212,902 | 118,555,073 | 109,526,053 | |
| EBITDA | $-56M | $-177M | $-213M |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $227M | $69M | $201M | |
| Receivables | $14M | $11M | $0 | |
| Inventory | · | $26M | $0 | |
| Prepaid Expense | $7M | $20M | $24M | |
| Other Current Assets | · | $4M | · | |
| Current Assets | $247M | $101M | $225M | |
| PP&E (Net) | $1M | $2M | $2M | |
| Other Non-current Assets | $110.0K | $34.0K | $175.0K | |
| Total Assets | $277M | $130M | $229M | |
| Accounts Payable | $14M | $10M | $8M | |
| Accrued Liabilities | $19M | $50M | $41M | |
| Current Liabilities | $34M | $62M | $50M | |
| Capital Leases | $1M | $0 | $722.0K | |
| Other Non-current Liabilities | · | $0 | $700.0K | |
| Total Liabilities | $35M | $62M | $52M | |
| Common Stock | $28.0K | $12.0K | $11.0K | |
| Retained Earnings | $-954M | $-902M | $-732M | |
| AOCI | $-41.0K | $-5.0K | $-13.0K | |
| Stockholders' Equity | $242M | $68M | $177M | |
| Liabilities + Equity | $277M | $130M | $229M | |
| Shares Outstanding | 281,987,033 | 119,835,162 | 110,160,684 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $12M | $20M | $19M | |
| Operating Cash Flow | $-58M | $-170M | $-173M | |
| CapEx | $155.0K | $140.0K | $615.0K | |
| Investing Cash Flow | $-155.0K | $-140.0K | $281M | |
| Stock Issued | $254.0K | $223.0K | $240.0K | |
| Stock Repurchased | · | $0 | $1.0K | |
| Net Stock Activity | $254.0K | $223.0K | $239.0K | |
| Financing Cash Flow | $216M | $39M | $1M | |
| Net Change in Cash | $157M | $-131M | $109M | |
| Free Cash Flow | $-58M | $-171M | $-174M |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -104.0% | -696.8% | · | |
| Net Margin | -98.2% | -669.4% | · | |
| EBITDA Margin | -104.0% | -696.8% | · | |
| ROA | -25.8% | -94.8% | -64.9% | |
| ROE | -36.9% | -225.5% | -93.7% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.2 | 1.6 | 4.5 | |
| Quick Ratio | 7.0 | 1.3 | 4.0 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | · | |
| Receivables Turnover | 4.3 | 4.7 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 110.5% | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $53M | $25M | $0 | |
| Net Income TTM | $-52M | $-170M | $-199M | |
| Market Cap | $697M | $53M | $434M | |
| P/E | -8.2 | -0.3 | -2.2 | |
| P/S | 13.0 | 2.1 | · | |
| P/B | 2.9 | 0.8 | 2.4 | |
| P / Tangible Book | 2.9 | 0.8 | 2.4 | |
| P / Cash Flow | -12.0 | -0.3 | -2.5 | |
| P / FCF | -11.9 | -0.3 | -2.5 | |
| Earnings Yield | -12.2% | -322.8% | -45.9% |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $14M | $17M | $13M | $12M | $11M | $14M | $9M | $2M | $0 | $0 | $0 | $0 | |
| R&D Expense | $29M | $31M | $10M | $8M | $10M | $11M | $18M | $58M | $30M | $31M | $62M | $26M | $44M | |
| SG&A Expense | $29M | $25M | $19M | $15M | $17M | $17M | $14M | $13M | $21M | $15M | $15M | $13M | $10M | |
| Operating Expenses | $60M | $57M | $30M | $24M | $27M | $28M | $33M | $72M | $52M | $46M | $77M | $43M | $54M | |
| Operating Income | $-46M | $-43M | $-13M | $-11M | $-15M | $-17M | $-19M | $-62M | $-49M | $-46M | $-77M | $-43M | $-54M | |
| Other Non-op | $1M | $2M | $1M | $553.0K | $400.0K | $633.0K | $786.0K | $2M | $2M | $3M | $3M | $4M | $4M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-44M | $-41M | $-11M | $-10M | $-15M | $-16M | $-18M | $-61M | $-47M | $-43M | $-74M | $-39M | $-50M | |
| EPS (Basic) | $-0.14 | $-0.13 | $0.02 | $-0.06 | $-0.12 | $-0.14 | $-0.14 | $-0.51 | $-0.40 | $-0.38 | $-0.67 | $-0.36 | $-0.46 | |
| EPS (Diluted) | $-0.14 | $-0.13 | $0.02 | $-0.06 | $-0.12 | $-0.14 | $-0.14 | $-0.51 | $-0.40 | $-0.38 | $-0.67 | $-0.36 | $-0.46 | |
| Shares (Basic) | 320,435,078 | 309,670,101 | -237,856,574 | 170,169,865 | 120,016,132 | 119,883,479 | -235,921,090 | 119,495,284 | 119,362,670 | 115,618,209 | -218,464,349 | 109,754,812 | 109,450,071 | |
| Shares (Diluted) | 320,435,078 | 309,670,101 | -237,856,574 | 170,169,865 | 120,016,132 | 119,883,479 | -235,921,090 | 119,495,284 | 119,362,670 | 115,618,209 | -218,464,349 | 109,754,812 | 109,450,071 | |
| EBITDA | $-46M | $-43M | · | $-11M | $-15M | $-17M | · | $-62M | $-49M | $-46M | · | $-43M | $-54M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $184M | $227M | $85M | $35M | $48M | $69M | $107M | $148M | $189M | $201M | $182M | $122M | |
| Receivables | $11M | $12M | $14M | $10M | $9M | $9M | $11M | $8M | $3M | · | $0 | · | · | |
| Inventory | · | · | · | $25M | $25M | $25M | · | $27M | $5M | $109.0K | $0 | · | · | |
| Prepaid Expense | $11M | $9M | $7M | $15M | $16M | $19M | $20M | $9M | $17M | $20M | $24M | $5M | $12M | |
| Other Current Assets | · | · | · | · | $2M | · | · | · | · | · | · | · | · | |
| Current Assets | $182M | $205M | $247M | $110M | $59M | $76M | $101M | $151M | $173M | $210M | $225M | $270M | $310M | |
| PP&E (Net) | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $1M | $1M | $110.0K | $6.0K | $15.0K | $24.0K | $34.0K | $7M | $2M | $2M | $175.0K | $187.0K | $291.0K | |
| Total Assets | $219M | $242M | $277M | $139M | $89M | $104M | $130M | $162M | $177M | $215M | $229M | $275M | $315M | |
| Accounts Payable | $9M | $2M | $14M | $18M | $18M | $9M | $10M | $18M | $7M | $1M | $8M | $9M | $4M | |
| Accrued Liabilities | $20M | $28M | $19M | $25M | $25M | $40M | $50M | $59M | $27M | $34M | $41M | $16M | $27M | |
| Current Liabilities | $31M | $32M | $34M | $44M | $44M | $50M | $62M | $79M | $37M | $36M | $50M | $27M | $33M | |
| Capital Leases | $7M | $7M | $1M | $2M | $2M | $0 | $0 | $219.0K | $0 | $625.0K | $722.0K | $927.0K | $1M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | $700.0K | $700.0K | · | |
| Total Liabilities | $38M | $39M | $35M | $46M | $46M | $50M | $62M | $79M | $37M | $37M | $52M | $28M | $34M | |
| Common Stock | $29.0K | $28.0K | $28.0K | $22.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $11.0K | $11.0K | $11.0K | |
| Retained Earnings | $-1.04B | $-996M | $-954M | $-943M | $-933M | $-918M | $-902M | $-884M | $-823M | $-776M | $-732M | $-658M | $-619M | |
| AOCI | $-35.0K | $-37.0K | $-41.0K | $-41.0K | $-39.0K | $-13.0K | $-5.0K | $-18.0K | $-12.0K | $-12.0K | $-13.0K | $-2.0K | $-22.0K | |
| Stockholders' Equity | $181M | $203M | $242M | $93M | $43M | $54M | $68M | $83M | $141M | $178M | $177M | $246M | $282M | |
| Liabilities + Equity | $219M | $242M | $277M | $139M | $89M | $104M | $130M | $162M | $177M | $215M | $229M | $275M | $315M | |
| Shares Outstanding | 294,755,090 | 282,803,863 | 281,987,033 | 214,409,450 | 120,142,811 | 119,961,445 | 119,835,162 | 119,604,035 | 119,442,635 | 119,221,230 | 110,160,684 | 109,846,329 | 109,570,333 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $8M | $5M | $4M | $4M | $5M | |
| Operating Cash Flow | $-43M | $-42M | $-15M | $-8M | $-13M | $-21M | $-38M | $-41M | $-42M | $-50M | $-59M | $-35M | $-37M | |
| CapEx | $510.0K | $726.0K | $0 | $0 | $11.0K | $144.0K | $-5.0K | $5.0K | $0 | $140.0K | $0 | $0 | $-9.0K | |
| Investing Cash Flow | $-510.0K | $-726.0K | $0 | $0 | $-11.0K | $-144.0K | $5.0K | $-5.0K | $0 | $-140.0K | $78M | $95M | $33M | |
| Stock Issued | $120.0K | $135.0K | $76.0K | $56.0K | $78.0K | $44.0K | $32.0K | $27.0K | $75.0K | $89.0K | $44.0K | $57.0K | $56.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | $1.0K | |
| Net Stock Activity | · | $135.0K | · | · | · | $44.0K | · | · | · | $89.0K | · | · | · | |
| Financing Cash Flow | $19M | $-98.0K | $157M | $58M | $131.0K | $10.0K | $77.0K | $61.0K | $92.0K | $39M | $141.0K | $92.0K | $270.0K | |
| Net Change in Cash | $-24M | $-43M | $142M | $50M | $-13M | $-21M | $-38M | $-41M | $-42M | $-11M | $19M | $60M | $-5M | |
| Free Cash Flow | · | $-42M | · | · | · | $-21M | · | · | · | $-50M | · | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -320.8% | -313.9% | · | -84.0% | -127.8% | -149.7% | · | -670.0% | -2175.2% | · | · | · | · | |
| Net Margin | -310.8% | -301.2% | · | -79.8% | -124.4% | -144.1% | · | -653.1% | -2086.9% | · | · | · | · | |
| EBITDA Margin | -320.8% | -313.9% | · | -84.0% | -127.8% | -149.7% | · | -670.0% | -2175.2% | · | · | · | · | |
| ROA | -28.8% | -24.0% | · | -7.0% | -11.0% | -10.2% | · | -27.8% | -19.2% | -15.4% | · | -11.3% | -12.6% | |
| ROE | -39.7% | -32.2% | · | -11.9% | -16.0% | -14.0% | · | -36.9% | -22.4% | -17.2% | · | -12.6% | -14.4% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 6.5 | · | 2.5 | 1.3 | 1.5 | · | 1.9 | 4.7 | 5.8 | · | 10.1 | 9.5 | |
| Quick Ratio | 5.5 | 6.2 | · | 2.1 | 1.0 | 1.1 | · | 1.5 | 4.1 | 5.2 | · | 6.8 | 3.8 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 2.0 | 2.6 | · | 2.3 | 1.6 | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $53M | $50M | · | $46M | $35M | $23M | · | $12M | $2M | · | · | · | · | |
| Net Income TTM | $-111M | $-83M | · | $-102M | $-139M | $-168M | · | $-191M | $-180M | $-168M | · | $-170M | $-182M | |
| Market Cap | $257M | $368M | · | $236M | $86M | $73M | · | $122M | $131M | $529M | · | $187M | $115M | |
| P/E | -1.9 | -2.9 | · | -1.3 | -0.6 | -0.4 | · | -0.6 | -0.7 | -2.9 | · | -1.1 | -0.6 | |
| P/S | 4.9 | 7.4 | · | 5.2 | 2.5 | 3.2 | · | 10.5 | 58.0 | · | · | · | · | |
| P/B | 1.4 | 1.8 | · | 2.5 | 2.0 | 1.3 | · | 1.5 | 0.9 | 3.0 | · | 0.8 | 0.4 | |
| P / Tangible Book | 1.4 | 1.8 | · | 2.5 | 2.0 | 1.3 | · | 1.5 | 0.9 | 3.0 | · | 0.8 | 0.4 | |
| P / Cash Flow | · | -8.8 | · | · | · | -3.4 | · | · | · | -10.5 | · | · | · | |
| P / FCF | · | -8.7 | · | · | · | -3.4 | · | · | · | -10.5 | · | · | · | |
| Earnings Yield | -51.6% | -34.6% | · | -75.4% | -163.6% | -236.4% | · | -161.8% | -145.4% | -34.2% | · | -91.8% | -159.1% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $53M | $25M | $0 | — | — |
| Betriebsgewinnmarge % | -104.0% | -696.8% | — | — | — |
| Nettoergebnis | $-52M | $-170M | $-199M | $-241M | $-227M |
| Verwässerte EPS | $-0.30 | $-1.43 | $-1.81 | $-2.23 | $-5.32 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 7.2 | 1.6 | 4.5 | 15.1 | — |
| Quick Ratio | 7.0 | 1.3 | 4.0 | 3.7 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-58M | $-171M | $-174M | $-222M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 140 Einreicher · $229.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 37 (-2 vs. Vorquartal) | 42 (+28 vs. Vorquartal) | 37 (+1 vs. Vorquartal) | 28 (-3 vs. Vorquartal) | -32.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $42.857.157 | 33.094.330 | 18,68% | Aktien |
| BVF INC/IL | $24.571.146 | 28.165.000 | 10,71% | Aktien |
| VANGUARD GROUP INC | $23.568.997 | 9.542.104 | 10,27% | Aktien |
| MAVERICK CAPITAL LTD | $16.550.225 | 18.970.913 | 7,21% | Aktien |
| PERCEPTIVE ADVISORS LLC | $16.131.231 | 18.490.636 | 7,03% | Aktien |
| Mithril II GP LP | $12.365.738 | 11.241.580 | 5,39% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.152.954 | 10.496.507 | 3,99% | Aktien |
| M28 Capital Management LP | $8.068.173 | 9.248.250 | 3,52% | Aktien |
| Saturn V Capital Management LP | $7.321.432 | 8.392.288 | 3,19% | Aktien |
| Soleus Capital Management, L.P. | $6.725.093 | 7.708.727 | 2,93% | Aktien |
| Point72 Asset Management, L.P. | $6.579.694 | 7.542.061 | 2,87% | Aktien |
| Siren, L.L.C. | $4.362.000 | 5.000.000 | 1,90% | Aktien |
| Driehaus Capital Management LLC | $4.193.228 | 4.806.543 | 1,83% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.036.453 | 4.625.437 | 1,76% | Aktien |
| ADAR1 Capital Management, LLC | $3.321.599 | 3.807.427 | 1,45% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3.194.275 | 3.661.480 | 1,39% | Aktien |
| STATE STREET CORP | $3.016.260 | 3.457.428 | 1,31% | Aktien |
| Qube Research & Technologies Ltd | $2.896.576 | 3.320.238 | 1,26% | Aktien |
| Ikarian Capital, LLC | $2.317.592 | 2.656.570 | 1,01% | Aktien |
| Redmile Group, LLC | $2.266.285 | 2.597.759 | 0,99% | Aktien |
| TWO SIGMA ADVISERS, LP | $2.264.002 | 916.600 | 0,99% | Aktien |
| 683 Capital Management, LLC | $2.165.770 | 2.482.543 | 0,94% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.035.723 | 2.333.474 | 0,89% | Aktien |
| Eversept Partners, LP | $1.951.572 | 2.237.015 | 0,85% | Aktien |
| Ensign Peak Advisors, Inc | $1.501.641 | 1.721.276 | 0,65% | Aktien |
| Boxer Capital Management, LLC | $1.308.600 | 1.500.000 | 0,57% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.272.258 | 1.459.012 | 0,55% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.236.262 | 1.417.732 | 0,54% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.051.765 | 1.205.599 | 0,46% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $868.329 | 995.334 | 0,38% | Aktien |
| GOLDMAN SACHS GROUP INC | $792.178 | 908.044 | 0,35% | Aktien |
| DEUTSCHE BANK AG\ | $687.952 | 790.749 | 0,30% | Aktien |
| CITADEL ADVISORS LLC | $680.840 | 780.422 | 0,30% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $675.792 | 774.635 | 0,29% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $409.781 | 469.717 | 0,18% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $397.412 | 455.539 | 0,17% | Aktien |
| CANTOR FITZGERALD, L. P. | $392.680 | 450.115 | 0,17% | Aktien |
| EMERALD MUTUAL FUND ADVISERS TRUST | $374.126 | 428.847 | 0,16% | Aktien |
| Virtus Investment Advisers, LLC | $370.712 | 424.933 | 0,16% | Aktien |
| Birchview Capital, LP | $298.601 | 342.275 | 0,13% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $281.097 | 323.100 | 0,12% | Verkaufsoption |
| Nuveen, LLC | $244.563 | 280.333 | 0,11% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $241.599 | 277.700 | 0,11% | Kaufoption |
| Squarepoint Ops LLC | $201.939 | 231.475 | 0,09% | Aktien |
| MML INVESTORS SERVICES, LLC | $178.350 | 204.436 | 0,08% | Aktien |
| Bank of New York Mellon Corp | $159.450 | 182.772 | 0,07% | Aktien |
| WELLS FARGO & COMPANY/MN | $153.783 | 176.276 | 0,07% | Aktien |
| Verdad Advisers, LP | $150.381 | 172.376 | 0,07% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $150.020 | 115.400 | 0,07% | Aktien |
| FMR LLC | $144.476 | 165.607 | 0,06% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $141.320 | 161.989 | 0,06% | Aktien |
| CITADEL ADVISORS LLC | $138.363 | 158.600 | 0,06% | Kaufoption |
| RHUMBLINE ADVISERS | $137.416 | 157.594 | 0,06% | Aktien |
| Jain Global LLC | $135.441 | 155.251 | 0,06% | Aktien |
| BANK OF AMERICA CORP /DE/ | $121.737 | 139.607 | 0,05% | Aktien |
| JANE STREET GROUP, LLC | $116.989 | 134.100 | 0,05% | Kaufoption |
| MetLife Investment Management, LLC | $116.727 | 133.800 | 0,05% | Aktien |
| Miller Financial Services LLC | $116.029 | 133.000 | 0,05% | Aktien |
| SIMON QUICK ADVISORS, LLC | $92.959 | 106.555 | 0,04% | Aktien |
| CITIGROUP INC | $87.701 | 100.528 | 0,04% | Aktien |
| Knott David M Jr | $87.240 | 100.000 | 0,04% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $86.542 | 99.200 | 0,04% | Aktien |
| Voleon Capital Management LP | $84.809 | 97.214 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $84.554 | 96.921 | 0,04% | Aktien |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | $84.193 | 96.507 | 0,04% | Aktien |
| EMERALD ADVISERS, LLC | $78.462 | 89.938 | 0,03% | Aktien |
| Invesco Ltd. | $73.226 | 83.936 | 0,03% | Aktien |
| a16z Perennial Management, L.P. | $69.678 | 79.869 | 0,03% | Aktien |
| XTX Topco Ltd | $63.276 | 72.531 | 0,03% | Aktien |
| China Universal Asset Management Co., Ltd. | $63.238 | 72.487 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $60.398 | 69.264 | 0,03% | Aktien |
| MORGAN STANLEY | $59.171 | 67.826 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $54.158 | 62.079 | 0,02% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $53.042 | 60.800 | 0,02% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $51.657 | 59.213 | 0,02% | Aktien |
| Rangeley Capital, LLC | $51.472 | 59.000 | 0,02% | Aktien |
| BARCLAYS PLC | $47.513 | 54.462 | 0,02% | Aktien |
| Nuveen Asset Management, LLC | $47.464 | 107.119 | 0,02% | Aktien |
| Cubist Systematic Strategies, LLC | $46.217 | 42.015 | 0,02% | Aktien |
| Scientech Research LLC | $46.144 | 52.893 | 0,02% | Aktien |
| JANE STREET GROUP, LLC | $37.164 | 42.600 | 0,02% | Verkaufsoption |
| BNP PARIBAS FINANCIAL MARKETS | $36.709 | 42.078 | 0,02% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $35.425 | 40.606 | 0,02% | Aktien |
| ProShare Advisors LLC | $32.471 | 37.220 | 0,01% | Aktien |
| Point72 Asia (Singapore) Pte. Ltd. | $31.200 | 28.364 | 0,01% | Aktien |
| NORTHERN TRUST CORP | $28.793 | 33.004 | 0,01% | Aktien |
| PRUDENTIAL FINANCIAL INC | $28.658 | 32.850 | 0,01% | Aktien |
| Abel Hall, LLC | $26.846 | 30.772 | 0,01% | Aktien |
| Massar Capital Management, LP | $24.665 | 28.273 | 0,01% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $23.605 | 27.058 | 0,01% | Aktien |
| CITADEL ADVISORS LLC | $23.555 | 27.000 | 0,01% | Verkaufsoption |
| BlackRock, Inc. | $21.145 | 24.238 | 0,01% | Aktien |
| JPMORGAN CHASE & CO | $20.763 | 22.002 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $20.416 | 23.402 | 0,01% | Aktien |
| OXFORD FINANCIAL GROUP, LTD. LLC | $20.147 | 23.094 | 0,01% | Aktien |
| ArchPoint Investors | $20.065 | 23.000 | 0,01% | Aktien |
| Cetera Investment Advisers | $20.065 | 23.000 | 0,01% | Aktien |
| Vanguard Personalized Indexing Management, LLC | $18.898 | 21.662 | 0,01% | Aktien |
| US BANCORP \DE\ | $17.884 | 20.500 | 0,01% | Aktien |
| Legal & General Group Plc | $17.827 | 20.435 | 0,01% | Aktien |
Unternehmensinsider 31 Insider · 14 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David Hering | Chief Executive Officer | 18. Dezember 2023 A | 8.000 | 0 | 0 | $0 |
| Tillman U. Gerngross | Chief Executive Officer | 30. Januar 2022 A | 27.845.995 | 0 | 0 | $0 |
| William E. Duke | Chief Financial Officer | 15. August 2026 M | 168.937 | 0 | 6 | $-124.882 |
| Jane Henderson | Chief Financial Officer | 30. Januar 2022 A | — | 0 | 0 | $0 |
| Jeremy Gowler | COO & CCO | 18. Dezember 2023 A | — | 0 | 0 | $0 |
| Timothy Edward Lee | Chief Commercial Officer | 15. August 2026 M | 178.937 | 0 | 6 | $-124.882 |
| Julie Green | Chief Human Resources Officer | 15. August 2026 M | 168.937 | 0 | 6 | $-124.882 |
| Robert D. Allen III | Chief Scientific Officer | 15. August 2026 M | 178.765 | 0 | 6 | $-115.517 |
| Jill Andersen | Chief Legal Officer, Secretary | 15. August 2026 M | 283.774 | 0 | 6 | $-208.126 |
| Stacy Price | Chief Tech. and Manuf. Officer | 18. Dezember 2023 A | — | 0 | 0 | $0 |
| Peter Schmidt | Chief Medical Officer | 18. Dezember 2023 A | — | 0 | 0 | $0 |
| Rebecca Dabora | Chief Tech and Manuf Officer | 14. Dezember 2022 A | — | 0 | 0 | $0 |
| Lynn Connolly | Chief Medical Officer | 30. Januar 2022 A | — | 0 | 0 | $0 |
| Elham Hershberger | Chief Development Officer | 30. Januar 2022 A | — | 0 | 0 | $0 |
| Tamsin Berry | Direktor | 19. Mai 2026 A | — | 0 | 0 | $0 |
| Ajay Royan | Direktor | 19. Mai 2026 A | 11.241.580 | 0 | 0 | $0 |
| Paul Bolno | Direktor | 19. Mai 2026 A | — | 0 | 0 | $0 |
| Kevin F Mclaughlin | Direktor | 19. Mai 2026 A | 50.000 | 1 | 0 | $125.000 |
| Terrance McGuire | Direktor | 19. Mai 2026 A | 3.066.757 | 0 | 0 | $0 |
| Christine Lindenboom | Direktor | 20. Mai 2025 A | — | 0 | 0 | $0 |
| Srishti Gupta | Direktor | 21. Mai 2024 A | — | 0 | 0 | $0 |
| Sara Cotter | Direktor | 21. Mai 2024 A | — | 0 | 0 | $0 |
| Tomas J. Heyman | Direktor | 23. Mai 2023 A | — | 0 | 0 | $0 |
| Clive Meanwell | Direktor | 23. Mai 2023 A | — | 0 | 0 | $0 |
| Michael S Wyzga | Direktor | 23. Mai 2023 A | — | 0 | 0 | $0 |
| Redonda Miller | Direktor | 22. Juni 2022 A | — | 0 | 0 | $0 |
| Howard Mayer | Direktor | 22. Juni 2022 A | — | 0 | 0 | $0 |
| Ellen R Marram | Direktor | 19. November 2021 A | — | 0 | 0 | $0 |
| Rene Russo | Direktor | 5. August 2021 A | — | 0 | 0 | $0 |
| Adimab, LLC | 10%-Eigentümer | 19. Januar 2024 S | 21.687.906 | 0 | 0 | $0 |
| Michael Mina | — | 31. Juli 2026 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Adimab, LLC ×6 Einreichungen | 29. Dezember 2025 | 7,30% | Änderung | — | SEC |
| Mithril II LP, Mithril II GP LP, Mithril II UGP LLC, Ajay Royan, Peter Thiel ×6 Einreichungen | 12. November 2025 | 4,80% | Änderung | — | SEC |
| Polaris Venture Partners V, L.P., Polaris Venture Partners Entrepreneurs' Fund V, L.P., Polaris Venture Partners Founders' Fund V, L.P., Polaris Venture Partners Special Founders' Fund V, L.P., Polaris Venture Management Co. V, L.L.C., Polaris Partners IX, L.P., Polaris Partners GP IX, L.L.C., Polaris Healthcare Technology Opportunities Fund, L.P., Polaris Healthcare Technology Opportunities Fund GP, L.L.C., Terrance McGuire, Jonathan Flint ×6 Einreichungen | 7. November 2025 | 3,00% | Änderung | — | SEC |
| M28 Capital Management LP, Marc Elia ×5 Einreichungen | 26. August 2025 | 4,60% | Änderung | — | SEC |
| Population Health Equity Partners III, L.P., Population Health Equity Partners III GP, LLC, Population Health Equity Partners VII, L.P., Population Health Equity Partners VII GP, LLC, Clive Meanwell, Christopher Cox ×3 Einreichungen | 24. Juni 2022 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 14 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,45% | 118.970 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,09% | 329.668 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,03% | 706.398 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,02% | 10.244 NS | 31. Mai 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 15.871 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1.216.850 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 182.982 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,01% | 2.005.803 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 352.912 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 5.264.148 SH | 8. August 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 589.970 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 2.434.423 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 7.785.522 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 17.900 SH | 8. August 2026 | Täglich |